New research being conducted at the University of Bergen in Norway indicates that Warfarin, a commonly prescribed blood thinner may lower the risk of developing cancer. While lead researcher James Lorens cautioned that the observational study, conducted on 1.25 million Norwegian people aged 50 and older, does not "prove a cause and effect relationship...[that] warfarin reduced the risk of cancer", cancer models have determined that warfarin blocks the AXL receptor on tumor cells.
To read more about this report, click here.
No comments:
Post a Comment